DBV Technologies Logo

DBV Technologies

DBV | PA

Overview

Corporate Details

ISIN(s):
FR0010417345 (+3 more)
LEI:
969500PVBQFWQKVDMD80
Country:
France
Address:
107 AVENUE DE LA REPUBLIQUE, 92320 CHATILLON
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

DBV Technologies is a clinical-stage biopharmaceutical company focused on developing treatments for food allergies. The company's core innovation is the VIASKIN® patch, a proprietary platform for epicutaneous immunotherapy (EPIT). This investigational technology is designed to re-educate the immune system by delivering minimal amounts of antigens to intact skin, offering a potential non-invasive therapeutic approach. DBV's development pipeline is led by its VIASKIN® Peanut patch (DBV712), which has advanced to Phase 3 clinical studies. The company is also researching applications for other food allergies, including milk. Founded by pediatricians, DBV aims to improve the lives of patients with potentially life-threatening allergies.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for DBV Technologies. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-20 12:46
Major Shareholding Notification
Franchissement de seuils
French 124.2 KB
2025-06-17 16:58
Major Shareholding Notification
Franchissement de seuils
French 107.2 KB
2025-06-12 22:05
Earnings Release
DBV Technologies to Participate in Upcoming EAACI Congress 2025
English 275.8 KB
2025-06-12 22:05
Regulatory News Service
DBV Technologies participera au prochain congrès EAACI 2025
French 269.7 KB
2025-06-11 22:30
Post-Annual General Meeting Information
DBV Technologies annonce les résultats de son Assemblée Générale Mixte 2025
French 179.9 KB
2025-06-11 22:30
Declaration of Voting Results & Voting Rights Announcements
DBV Technologies Announces the Voting Results of its 2025 Combined General Meet…
English 179.7 KB
2025-06-04 22:32
Declaration of Voting Results & Voting Rights Announcements
Information Regarding the Total Number of Voting Rights and Total Number of Sha…
English 169.6 KB
2025-06-04 22:32
Declaration of Voting Results & Voting Rights Announcements
Information relative au nombre total des droits de vote et d’actions composant…
French 150.3 KB
2025-06-03 22:30
Registration Form
DBV Technologies publie un amendement à son Document d’enregistrement universel…
French 178.9 KB
2025-06-03 22:30
Registration Form
DBV Technologies announces the filing of an addendum to the 2024 Universal Regi…
English 171.4 KB
2025-05-15 22:30
Pre-Annual General Meeting Information
Assemblée Générale Mixte du 11 juin 2025
French 173.8 KB
2025-05-15 22:30
Pre-Annual General Meeting Information
Combined General Meeting of June 11, 2025
English 193.4 KB
2025-05-06 22:30
Declaration of Voting Results & Voting Rights Announcements
Information regarding the total number of voting rights and  total number of s…
English 95.0 KB
2025-05-06 22:30
Declaration of Voting Results & Voting Rights Announcements
Information relative au nombre total des droits de vote et d’actions composant…
French 100.7 KB
2025-05-05 22:30
Regulatory News Service
DBV Technologies participera à la conférence Citizens JMP Life Sciences
French 174.6 KB

Automate Your Workflow. Get a real-time feed of all DBV Technologies filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for DBV Technologies via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2022-06-09 N/A Other Other 2,483,161 7,449,483.00 EUR

Peer Companies

Company Country Ticker View
THERACRYF PLC Logo
Developing sulforaphane-based therapeutics for oncology and behavioural brain disorders.
United Kingdom TCF
Theranexus Logo
Biopharma developing drug candidates for rare neurological diseases like Batten disease.
France ALTHX
TME Pharma N.V. Logo
Clinical-stage biotech developing TME-targeting therapies for aggressive cancers.
Germany ALTME
Toleranzia AB Logo
Developing immune therapies for rare autoimmune diseases like myasthenia gravis.
Sweden TOL
Transgene Logo
Clinical-stage biotech using viral vectors for cancer vaccines and oncolytic viruses.
France TNG
Tvardi Therapeutics Inc. Logo United States of America TVRD
UCAR Logo
A nonprofit consortium managing atmospheric research and providing resources to the scientific community.
France ALUCR
Hong Kong N/A
Urteste S.A. Logo
Developing non-invasive urine tests for early detection & monitoring of multiple cancers.
Poland URT
VALIRX PLC Logo
Developing early-stage therapeutics & diagnostics for oncology and women's health.
United Kingdom VAL